Clinical Treatment Guidelines for Tafasitamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Adrienne Nedved, Kami Maddocks, Grzegorz S. Nowakowski

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Clinical Treatment Guidelines for Tafasitamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences